MEDICAL FACILITIES CORP (DR.CA) Stock Analyst Ratings
TSX:DR - Toronto Stock Exchange - CA58457V5036 - Common Stock - Currency: CAD
ChartMill assigns a Buy % Consensus number of 42% to DR.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.58. This target is 11.54% above the current price.
DR.CA was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about DR.CA.
In the previous month the buy percentage consensus was at a similar level.
DR.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-12 | Leede Jones Gab | Downgrade | Hold |
| 2022-11-11 | RBC Royalbank | Downgrade | Sector Perform |
| 2022-11-11 | National Bank of Canada Financial | Downgrade | |
| 2022-09-15 | National Bank of Canada Financial | Initiate | Sector Perform |
| 2022-05-16 | RBC Royalbank | Downgrade | Sector Perform |
| 2022-05-13 | National Bank of Canada Financial | Downgrade | Sector Perform |
| 2022-03-11 | RBC Royalbank | Upgrade | Sector Perform |
| 2022-03-11 | National Bank of Canada Financial | Upgrade | Outperform |
| 2021-11-12 | NationalBankFinancial | Downgrade | Outperform |
| 2021-11-12 | RBCRoyalBank | Upgrade | Sector Perform |
| 2021-09-07 | National Bank Financial | Upgrade | Outperform |
| 2021-05-14 | National Bank Financial | Upgrade | Outperform |
| 2021-05-14 | RBC Capital | Upgrade | Sector Perform |
| 2021-03-15 | RBC Capital | Upgrade | Sector Perform |